Clinical Trials Logo

Apnea clinical trials

View clinical trials related to Apnea.

Filter by:

NCT ID: NCT03280914 Completed - Obesity Clinical Trials

Epidemiology and Intervention of Obstructive Sleep Apnea Based on Community

Start date: August 1, 2017
Phase:
Study type: Observational

This observational study in a real-world community was designed to perform epidemiological investigation and assess effect of CPAP intervention of obstructive sleep apnea.

NCT ID: NCT03277963 Completed - Obesity Clinical Trials

Perception of Pain During Obstructive Sleep Apnea Syndrome in Obese Patient

Start date: February 4, 2010
Phase: N/A
Study type: Interventional

Obstructive sleep apnea syndrome (SAOS), very commonly associated with obesity, induces major disturbances in sleep architecture. The hypotheses in this work are twofold: on the one hand, the SAOS could generate pain perception disorders in a population already affected by the mechanical weight constraints, generating potentially painful complications, and on the other hand, the improvement of sleep provided by continuous positive airway pressure (PPC) ventilation could "normalize" the pain perception thresholds. It was shown an early rebound effect after treatment on increasing pain threshold in the healthy subject. We want to check it among obese patients with OSA in early and mid-term.

NCT ID: NCT03272763 Completed - Clinical trials for Obstructive Sleep Apnea

A Development Study to Evaluate a Full-Face Mask for the Treatment of Obstructive Sleep Apnea

Start date: October 9, 2017
Phase: N/A
Study type: Interventional

This investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.

NCT ID: NCT03271827 Completed - Apnoeic Oxygenation Clinical Trials

Apnoeic Oxygenation by Nasal Cannula During Airway Management in Children Undergoing General Anaesthesia.

Start date: January 2016
Phase: N/A
Study type: Interventional

Airway management is a core clinical skill in anaesthesia. Pre-oxygenation prior to induction of anaesthesia is standard practice to prevent desaturation. Apnoeic oxygenation in adults is effective and prolongs the time to desaturation. The effectiveness of apnoeic oxygenation in the adult is well document, however evidence in the paediatric is lacking. Therefore, the aim of this study was to investigate the effectiveness of apnoeic oxygenation during airway management in children. This was a pilot randomised controlled trial. Patients were randomised to either receive apnoeic oxygenation or standard care during the induction of anaesthesia. The primary outcome was the duration of safe apnoea, defined as a composite of the time to first event, either time for SpO2 to drop to 92% or time to successfully secure the airway, and the lowest SpO2 observed during airway management. Secondary outcomes were number of patients whose SpO2 dropped below 95% and number of patients whose SpO2 dropped below 92%.

NCT ID: NCT03268473 Completed - Clinical trials for Obstructive Sleep Apnea

Effect of Non-surgical Periodontal Treatment on Oxidative Stress and Antioxidant Status in OSAS

OSAS
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The main objective of this study is to compare the effect of the non-surgical periodontal treatment on serum and saliva oxidative stress parameters in patients with periodontitis and obstructive sleep apnea syndrome (OSAS) and in patients with periodontitis only.

NCT ID: NCT03267927 Completed - Clinical trials for Obstructive Sleep Apnea Syndrome

Management of Obstructive Sleep Apnea (OSA) in Children and Maxillary and Mandibular Development

SAOS
Start date: November 5, 2017
Phase: N/A
Study type: Interventional

Assessment of the association of maxillary expansion using a rapid palatal expansion, use of a mandibular advancement appliance (MGA™) and of a device allowing sleep in a semi-seated position (Yoobreath™) in patients with Obstructive Sleep Apnea (OAS). MGA™ and YooBreath™ constitute the Yookid system™.

NCT ID: NCT03262519 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

The Effect of Obstructive Sleep Apnea and Its Treatment on Decision Making

Start date: July 20, 2017
Phase:
Study type: Observational

Obstructive sleep apnea (OSA) is an extremely common disease with inadequately explored neurocognitive consequences. The investigators will study OSA patients before and after treatment to understand how OSA changes decision making abilities, and whether treatment can reverse such cognitive changes. These results could provide deeper insight into how OSA affects decision making either temporarily or permanently, and provide another rationale or motivation for treatment of OSA in adults.

NCT ID: NCT03257488 Recruiting - Clinical trials for Sleep Apnea, Obstructive

Screening of Obstructive Sleep Apnea Syndrome in Patients With Resistant Systemic Arterial Hypertension: Pilot Study

Start date: April 2015
Phase: N/A
Study type: Interventional

This study evaluates the utility and reliability of Somnocheck micro Weinmann for obstructive sleep apnea syndrome (OSAS) screening in patients affected by resistant systemic arterial hypertension. Results are compared with a modified portable sleep apnea testing (type III portable monitoring: Somnocheck 2 Weinmann).

NCT ID: NCT03255408 Not yet recruiting - Stroke Clinical Trials

Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia

Start date: January 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

A prospective double blind, placebo-controlled, randomized cross-over trial to evaluate the effect of lowering cerebral blood flow on the ventilatory chemoreflexes (acute hypoxic and hypercapnic ventilatory responses).

NCT ID: NCT03254212 Recruiting - Clinical trials for Chronic Heart Failure

Nocturnal Oxygen Needs and Central Sleep Apnea in Patients With Chronic Heart Failure.

HO2F
Start date: April 15, 2018
Phase: Phase 4
Study type: Interventional

The aims of this study are to 1) determine the optimal levels of O2 flow which prevent nocturnal O2 desaturation while minimizing periods of hyperoxia during the course of nocturnal oxygen therapy (NOXT) in heart failure patients with reduced ejection fraction (HFrEF) patients with CSA/CSR; 2) document whether within-patient EO2F values change over time during NOXT, and identify factors which predict changes in EO2F; and 3) examine how well a conventional stepwise titration procedure compares to a breath by breath titration using an automated O2 titration system in terms of targeted flow rate and night time oxygenation (oxygen desaturation index, time spent at specific SpO2 targets).